Exenatide once weekly in type 2 diabetes mellitus

Expert Opin Pharmacother. 2011 Jun;12(8):1297-1303. doi: 10.1517/14656566.2011.573145.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Drug Administration Schedule
  • Exenatide
  • Glucagon-Like Peptide 1 / metabolism
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / economics
  • Peptides / administration & dosage*
  • Peptides / economics
  • Receptors, Glucagon / agonists
  • Time Factors
  • Treatment Outcome
  • Venoms / administration & dosage*
  • Venoms / economics

Substances

  • GLP1R protein, human
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Peptides
  • Receptors, Glucagon
  • Venoms
  • Glucagon-Like Peptide 1
  • Exenatide